Over 25 years of sales, marketing and executive leadership experience in both pharmaceutical and medical device with Johnson & Johnson in multiple therapeutic categories which include Aesthetics, CNS,  Analgesics, Biologics/Hemostasis, Urology, Infectious Diseases & Wound Care. Recently joined Cempra Inc. as the Vice President of Market Development. His primary responsibility is to develop commercialization plans for Solithromycin, the next-generation macrolide, the first fluoroketolide for community acquired pneumonia. Cempra Inc. is a clinical-stage pharmaceutical company focused on developing antibacterials to meet critical medical needs